168 related articles for article (PubMed ID: 17962633)
1. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
2. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
4. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.
Carpagnano GE; Palladino GP; Gramiccioni C; Foschino Barbaro MP; Martinelli D
Lung Cancer; 2010 May; 68(2):305-7. PubMed ID: 20188432
[TBL] [Abstract][Full Text] [Related]
5. Exhaled HPV infection in lung cancer: role of MA at 3p.
Carpagnano GE; Lacedonia D; Crisetti E; Palladino GP; Saliani V; Zoppo LD; Antonetti R; Natalicchio I; Foschino-Barbaro MP
Arch Med Res; 2014 Jul; 45(5):383-7. PubMed ID: 24962429
[TBL] [Abstract][Full Text] [Related]
6. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.
Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL
Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095
[TBL] [Abstract][Full Text] [Related]
7. How strong is the association between IPF and lung cancer? An answer from airway's DNA.
Carpagnano GE; Lacedonia D; Soccio P; Caccavo I; Patricelli G; Foschino Barbaro MP
Med Oncol; 2016 Nov; 33(11):119. PubMed ID: 27688240
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
9. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
10. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
11. Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene.
Kordiak J; Szemraj J; Hamara K; Bialasiewicz P; Nowak D
Respir Med; 2012 Sep; 106(9):1293-300. PubMed ID: 22795503
[TBL] [Abstract][Full Text] [Related]
12. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
Carpagnano GE; Lacedonia D; Palladino GP; Koutelou A; Martinelli D; Orlando S; Foschino-Barbaro MP
Eur J Clin Invest; 2012 May; 42(5):478-86. PubMed ID: 21955247
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer.
Yang Ai SS; Hsu K; Herbert C; Cheng Z; Hunt J; Lewis CR; Thomas PS
Respir Med; 2013 Jun; 107(6):911-8. PubMed ID: 23507584
[TBL] [Abstract][Full Text] [Related]
14. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
15. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
17. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
19. Exhaled matrix metalloproteinase-9 in lung cancer.
Carpagnano GE; Palladino GP; Martinelli D; Lacedonia D; Orlando S; Foschino-Barbaro MP
Rejuvenation Res; 2012 Aug; 15(4):359-65. PubMed ID: 22877564
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.
Jungraithmayr W; Frings C; Zissel G; Prasse A; Passlick B; Stoelben E
Respirology; 2008 Nov; 13(7):1022-7. PubMed ID: 18764914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]